ROYAL BANK OF CANADA - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G100. A total of 37 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$4,000
-60.0%
6,346
-51.0%
0.00%
Q2 2020$10,000
+25.0%
12,963
+63.9%
0.00%
Q1 2020$8,000
-42.9%
7,910
-7.0%
0.00%
Q4 2019$14,000
+16.7%
8,506
+24.0%
0.00%
Q3 2019$12,000
+33.3%
6,861
+24.7%
0.00%
Q2 2019$9,000
+50.0%
5,500
+76.1%
0.00%
Q1 2019$6,0000.0%3,123
+4.1%
0.00%
Q4 2018$6,000
-45.5%
3,000
-3.4%
0.00%
Q3 2018$11,000
+83.3%
3,106
+3.5%
0.00%
Q2 2018$6,0003,0000.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 41,909,219$21,793,00011.58%
Kore Private Wealth LLC 202,366$105,0000.02%
BARD ASSOCIATES INC 335,750$175,0000.02%
HighTower Advisors, LLC 5,284,688$2,738,0000.01%
GSA CAPITAL PARTNERS LLP 126,529$66,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 654,200$339,0000.01%
Virtu Financial LLC 57,076$30,0000.01%
WEDBUSH SECURITIES INC 81,500$42,0000.00%
MATRIX ASSET ADVISORS INC/NY 39,500$20,0000.00%
NEXPOINT ASSET MANAGEMENT, L.P. 33,933$18,0000.00%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders